Gilead announces positive Biktarvy data for HIV and hepatitis B - PMLiVE

8/1/2022 12:00:00 AM2 years 9 months ago

The results were presented at the 24th International AIDS Conference

Gilead Sciences has announced results supporting Biktarvy as a highly effective treatment for people with HIV, including those with HIV and hepatitis B (HBV) co-infection. Biktarvy is a complete HIV… [+2480 chars]

full article...